ArticlePublic health action2026
Compliance with intermittent preventive malaria treatment in pregnancy at a tertiary hospital in Sierra Leone.
Article in Public health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe receipt of intermittent preventive treatment for malaria in pregnancy (IPTp) doses, assess compliance with the recommended minimum of three IPTp doses, and identify factors associated with non-compliance among antenatal care attendees. This was a non-concurrent cohort study using routinely collected hospital data in 2024 at the Princess Christian Maternity Hospital, a university-affiliated tertiary teaching hospital in Freetown, Sierra Leone.
resultsAmong the 733 pregnant antenatal care attendees, 682 (93%) registered after the first trimester, and only 30 (4%) had ≥4 antenatal contacts. Of the 733, 406 (55%) received first dose and only 62 (8%) received three doses. The maximum number of doses received was six by a single woman. In adjusted analysis, women with less than four antenatal contacts had three times higher risk of non-compliance (adjusted relative risk: 2.7, 95% confidence interval: 1.6-4.5) compared with those with ≥4 contacts. Receipt of IPTp doses and compliance with the recommended minimum of three doses were low and were associated with fewer antenatal care contacts.
conclusionOur findings underscore the need to understand the reasons for the gaps in treatment and to address them systematically. Strategies to increase the number of antenatal care contacts may improve compliance with the recommended minimum three doses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.